Validose Raises $2M to Combat Clinical Trial Non-Adherence with AI-Powered Medication Delivery –
What You Ought to Know: – Validose, a 10XBeta Enterprise Studio portfolio firm pioneering precision remedy supply, introduced at ...
Read moreWhat You Ought to Know: – Validose, a 10XBeta Enterprise Studio portfolio firm pioneering precision remedy supply, introduced at ...
Read moreElizabeth Holmes, the founder and CEO of disgraced blood-testing firm Theranos, has been found guilty on ...
Read moreWhat You Ought to Know: – Owkin, an AI-powered biotech firm, as we speak introduced the ...
Read moreWhat You Ought to Know: – Medidata, a Dassault Systèmes model and a number one supplier ...
Read moreWhat You Ought to Know: – Cognizant (Nasdaq: CTSH) introduced an expanded settlement with Medidata, a Dassault Systèmes model and ...
Read moreThe concept was so tantalizing. Medicine within the GLP-1 class, which incorporates Wegovy and Ozempic, have ...
Read moreMADRID (AP) — The previous president of the Spanish soccer federation, Luis Rubiales, goes on trial ...
Read moreSean “Diddy” Combs Bryan Steffy/WireImage Sean “Diddy” Combs has reportedly been transported to an area hospital, ...
Read moreWhat You Ought to Know: – Medidata, a Dassault Systèmes model and a frontrunner in medical trial ...
Read moreBernard Arnault, France's richest man and the billionaire head of luxurious group LVMH, is about to ...
Read more© 2024 The Owner Press | All Rights Reserved
© 2024 The Owner Press | All Rights Reserved